Algiax Pharmaceuticals is a biopharmaceutical company in the clinical trial phase that was founded in 2011. The company is committed to discovering and creating novel treatments for illnesses that have a substantial unmet medical requirement.
Calcilytix Therapeutics
Headquarters
Germany